Trial intelligence / Profile preview

INGRESS: Clevidipine for Pre-induction Hypertension

NCT06063772Phase 4Not yet recruiting

Sponsor
University of California, San Diego
Start
Jan 2025
Primary completion
Dec 2025
Modality
Small Molecules
01

Overview

A Phase 4 trial of clevidipine in hypertension (HTN), sponsored by University of California, San Diego. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

clevidipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT06063772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06063772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call